Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of Nucleus(t)Ide Treated Patients Randomised to Tenofovir, or Tenofovir + Telbivudine

NCT02774837 is registered in ClinicalTrials.gov with Seng Gee Lim as lead sponsor.

NCT NCT02774837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of Nucleus(t)Ide Treated Patients Randomised to Tenofovir, or Tenofovir + Telbivudine
Lead sponsor
Seng Gee Lim
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2016
Completion date
July 31, 2020
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b